NEW YORK (360Dx) – The US Food and Drug Administration has cleared Roche Diagnostics' Cobas e 801 immunoassay analyzer for the in vitro determination of analytes in body fluids, the agency announced recently.

The agency also cleared Roche's Elecsys TSH immunoassay for the in vitro quantitative determination of thyrotropin in human serum and plasma. TSH measurements are used for diagnosing thyroid or pituitary disorders. The assay is intended for use on the Cobas e analyzers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.